Drug maker Plethico Pharmaceuticals today said it will split its stock in the ratio of 1:10.


</p><tr><td><p class='TableClas'></p><P class='TableClas'><DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>The board has approved the subdivision of equity shares of face value of Rs 10 into 10 shares of face value of Re 1, the company said in a filing to the Bombay Stock Exchange.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
</p><p class='TableClas'>Further, the board has declared a dividend of 25 per cent, at the rate of Rs 2.50 on shares of face value Rs 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares of Plethico Pharma closed at Rs 411.40, up 3.92 per cent on the BSE.</P></p><p class='TableClas'></p></table>


Plethico board approves 1:10 stock split

Also Read

Neyveli Lignite Corp net up Rs 384.68 cr

Supreme Petro, NOVA Chem ink agreement

US bankers say no to MTN funding

K Raheja to set up Mindspace IT park

OPTCL to install transmission lines

Explore News